These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8265709)

  • 21. Lipid-based systems for the enhanced delivery of poorly water soluble drugs.
    Porter CJ; Wasan KM; Constantinides P
    Adv Drug Deliv Rev; 2008 Mar; 60(6):615-6. PubMed ID: 18160174
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of cyclodextrin solubilization of drugs.
    Loftsson T; Hreinsdóttir D; Másson M
    Int J Pharm; 2005 Sep; 302(1-2):18-28. PubMed ID: 16099118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrochemical determination of partition coefficients of drugs.
    Kontturi K; Murtomäki L
    J Pharm Sci; 1992 Oct; 81(10):970-5. PubMed ID: 1432622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating drug solubility in the gastrointestinal tract.
    Dressman JB; Vertzoni M; Goumas K; Reppas C
    Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.
    Blagden N; de Matas M; Gavan PT; York P
    Adv Drug Deliv Rev; 2007 Jul; 59(7):617-30. PubMed ID: 17597252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temperature and solvent effects in the solubility of some pharmaceutical compounds: Measurements and modeling.
    Mota FL; Carneiro AP; Queimada AJ; Pinho SP; Macedo EA
    Eur J Pharm Sci; 2009 Jun; 37(3-4):499-507. PubMed ID: 19406228
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solubilization of monovalent weak electrolytes by micellization or complexation.
    He Y; Yalkowsky SH
    Int J Pharm; 2006 May; 314(1):15-20. PubMed ID: 16580158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theoretical study of gas-phase acidity, pKa, lipophilicity, and solubility of some biologically active sulfonamides.
    Remko M; von der Lieth CW
    Bioorg Med Chem; 2004 Oct; 12(20):5395-403. PubMed ID: 15388166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro release of chloramphenicol from different suppository bases.
    Kassem AA; Nour El-Din E; Abd El-Bary A; Fadel HM
    Pharmazie; 1975 Jul; 30(7):472-5. PubMed ID: 1178767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deviations of drug solubility in water-cosolvent mixtures from the Jouyban-Acree model--effect of solute structure.
    Jouyban A; Fakhree MA; Ghafourian T; Saei AA; Acree WE
    Pharmazie; 2008 Feb; 63(2):113-21. PubMed ID: 18380397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of molecular properties on oral bioavailability of lipophilic drugs - mapping of bulkiness and different measures of polarity.
    Kuentz MT; Arnold Y
    Pharm Dev Technol; 2009; 14(3):312-20. PubMed ID: 19235630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analytical methods for assay of ellagic acid and its solubility studies.
    Bala I; Bhardwaj V; Hariharan S; Kumar MN
    J Pharm Biomed Anal; 2006 Jan; 40(1):206-10. PubMed ID: 16111850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biopharmaceutical characterization of some synthetic purine drugs.
    Chrzanowska M; Kuehn M; Hermann T; Neubert RH
    Pharmazie; 2003 Jul; 58(7):504-6. PubMed ID: 12889537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solubility of drugs in aqueous solutions. Part 4. Drug solubility by the dilute approximation.
    Ruckenstein E; Shulgin I
    Int J Pharm; 2004 Jul; 278(2):221-9. PubMed ID: 15196627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Practical aspects of partition measurements according to GLP rules].
    Takácsné Novák K
    Acta Pharm Hung; 1997 Sep; 67(5):179-91. PubMed ID: 9432865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Physico-chemical profiling of centrally acting molecules for prediction of pharmacokinetic properties].
    Deák K
    Acta Pharm Hung; 2008; 78(3):110-20. PubMed ID: 18986088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of aqueous solubility estimation from AQUAFAC and the GSE.
    Jain P; Sepassi K; Yalkowsky SH
    Int J Pharm; 2008 Aug; 360(1-2):122-47. PubMed ID: 18514447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solubility of drugs in aqueous solutions. Part 5. Thermodynamic consistency test for the solubility data.
    Ruckenstein E; Shulgin I
    Int J Pharm; 2005 Mar; 292(1-2):87-94. PubMed ID: 15725556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.